Biomarkers for immunotherapy in bladder cancer: a moving target

by David H. Aggen, Charles G. Drake
Published 2017-11-01

Considerations for treatment duration in responders to immune checkpoint inhibitors

by Daniel Olson, Jiajia Zhang, Todd Bartkowiak, Abdul Rafeh Naqash, Vaia Florou, Rosa Nguyen, Rania H Younis, Sarah Church, Maria E Rodriguez-Ruiz, Rachel Howard, Thomas U Marron, Ravi B Patel, Michal Sheffer, Abigail Overacre-Delgoffe, Aideen E Ryan, Sangeetha M Reddy, Sabina Kaczanowska, Dipti Thakkar, Kristin G Anderson, Esha Sachdev, Christopher Fuhrman, Jessica E Thaxton, David H Aggen, Jennifer L Guerriero
Published 2021-03-01